Trial
NCT04974099
Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Crohn's and Colitis Foundation
Condition
Crohn Disease
Intervention
RoadMAB precision dashboard
Why stopped
This was the Pilot study. The larger, confirmatory study has started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-11